Altimmune, Inc. (ALT)
NASDAQ·Healthcare·Biotechnology
$3.27
+0.15%
Mkt Cap $635.93M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$6.25
Range $2.50 – $10.00
Implied Upside
+91.1%
Consensus $6.25 vs current $3.27
NASDAQ·Healthcare·Biotechnology
$3.27
+0.15%
Mkt Cap $635.93M
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$6.25
Range $2.50 – $10.00
+91.1%
Consensus $6.25 vs current $3.27